GEODE CAPITAL MANAGEMENT, LLC - TRANSCEPT PHARMACEUTICALS IN ownership

TRANSCEPT PHARMACEUTICALS IN's ticker is TSPT and the CUSIP is 89354M106. A total of 43 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TRANSCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2014$79,000
+2.6%
39,0400.0%0.00%
Q2 2014$77,000
-42.1%
39,040
-10.1%
0.00%
Q1 2014$133,000
-8.3%
43,412
+0.4%
0.00%
Q4 2013$145,000
+6.6%
43,253
+1.0%
0.00%
Q3 2013$136,000
+13.3%
42,811
+8.1%
0.00%
Q2 2013$120,00039,6140.00%
Other shareholders

There were no reported owners of TRANSCEPT PHARMACEUTICALS IN in Q3 2013.

NameSharesValueWeighting ↓
View complete list of TRANSCEPT PHARMACEUTICALS IN shareholders